Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

2,776 trials

Showing 20 of 2,776 results

Very early researchNot Yet RecruitingNCT07281404
What this trial is testing

FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL

Who this might be right for
Early-phase Safety and PK Study of a Vaginal Gel
Yaso Therapeutics Corporation 72
Early research (Phase 1)Study completedNCT01579149
What this trial is testing

A Phase I Dose Escalation Study of Plerixafor in Healthy Subjects of Japanese Descent

Who this might be right for
Healthy Volunteer
Genzyme, a Sanofi Company 24
Early research (Phase 1)Study completedNCT03580278
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2

Who this might be right for
Psoriasis
Affibody 33
Early research (Phase 1)Looking for participantsNCT06859333
What this trial is testing

Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers

Who this might be right for
InfluenzaViral Respiratory Infection
Valenta Pharm JSC 36
Early research (Phase 1)Study completedNCT05516121
What this trial is testing

VLT-015 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
CF Pharma, LLC 15
Large-scale testing (Phase 3)Study completedNCT03571516
What this trial is testing

Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome

Who this might be right for
Short Bowel Syndrome
Shire 10
Testing effectiveness (Phase 2)Study completedNCT01096784
What this trial is testing

IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity (ROP)
Shire 121
Early research (Phase 1)Not Yet RecruitingNCT07399899
What this trial is testing

Dose-Finding Study of NBX-100 in Healthy Adult Participants

Who this might be right for
Healthy Participants
Neurala Biosciences 8
Early research (Phase 1)Active Not RecruitingNCT06309043
What this trial is testing

A Randomized, Single Intravenous Dose, Parallel Phase I Clinical Study to Compare the Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX05 Vs. Erbitux® (Cetuximab) in Healthy Adult Male Chinese Subjects

Who this might be right for
EGFR Overexpression
Shanghai Henlius Biotech 268
Early research (Phase 1)UnknownNCT00002449
What this trial is testing

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

Who this might be right for
HIV Infections
Chiron Corporation 212
Large-scale testing (Phase 3)Study completedNCT02234115
What this trial is testing

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma

Who this might be right for
Prostatic Neoplasms
Foresee Pharmaceuticals Co., Ltd. 137
Testing effectiveness (Phase 2)Study completedNCT00139906
What this trial is testing

Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Solvay Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00820950
What this trial is testing

Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Incyte Corporation 29
Early research (Phase 1)Study completedNCT02215850
What this trial is testing

Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours

Who this might be right for
Solid Tumours
Welichem Biotech Inc. 24
Early research (Phase 1)Ended earlyNCT00932126
What this trial is testing

This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 35
Early research (Phase 1)Study completedNCT04534582
What this trial is testing

Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects

Who this might be right for
Healthy Male Volunteers
Shanghai Henlius Biotech 252
Early research (Phase 1)Study completedNCT06795906
What this trial is testing

A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma

Who this might be right for
Asthma
AstraZeneca 24
Testing effectiveness (Phase 2)Study completedNCT01222533
What this trial is testing

Tiotropium Respimat Pharmacokinetic Study in COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 154
Early research (Phase 1)Active Not RecruitingNCT07075640
What this trial is testing

Determine the Safety and Tolerability of AG-236 and How it is Absorbed, Broken Down, and Eliminated From the Body in Healthy Participants

Who this might be right for
Healthy Participants
Agios Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07780318
What this trial is testing

BL-M08D in Patients With Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors

Who this might be right for
Gastrointestinal TumorsSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation